XO Life is a digital health company whose brite™ platform connects patients, healthcare professionals, and pharma partners with AI-powered, personalised therapy support and digital aftercare.

XO Life is a leading digital health company headquartered in Munich, Germany, specialising in patient guidance and therapy support. Through its brite™ platform, the company provides a global meta‑platform that connects patients, healthcare professionals, and the pharmaceutical industry. The platform covers all diseases, treatments, and therapeutic areas, allowing pharma partners to deliver personalised medical insights and digital aftercare without building proprietary apps. Within just four years, XO Life has established market leadership in Germany, partnering with more than 40 pharmaceutical companies and key healthcare organizations. Its AI engine continuously learns from new patient interactions, creating a powerful data flywheel that enhances personalisation and strengthens the company’s regulatory moat. XO Life addresses a global SAM of €73bn, representing approximately 5,000 pharma companies across up to 30 brands and 195 countries. The solution enables the generation of proprietary real‑world patient data, supporting both clinical evidence needs and improved therapy outcomes. Thanks to its compliant infrastructure and strong regulatory expertise, XO Life has built one of the most defensible business models in the pharma technology space. The company demonstrates strong growth momentum, rapidly scaling ARR while showing proven market demand and exceptional sales efficiency. With expansion plans across Europe, the Middle East, and Africa, XO Life is positioned to become a global leader in connected, AI-powered pharma technology.